Comments on: Stem-cells are merely a policy diversion for lagging Connecticut http://yalepatents.org/2009/12/30/stem-cell-program-policy-diversion-for-a-lagging-connecticut/ Discussing Yale, intellectual property reform and biotech industry in New Haven and Connecticut. Sat, 10 Jul 2010 22:20:08 -0400 hourly 1 http://wordpress.org/?v=3.0 By: U.S. should fund high-tech research, not states | yalepatents.org http://yalepatents.org/2009/12/30/stem-cell-program-policy-diversion-for-a-lagging-connecticut/comment-page-1/#comment-174 U.S. should fund high-tech research, not states | yalepatents.org Thu, 07 Jan 2010 13:25:03 +0000 http://yalepatents.org/?p=617#comment-174 [...] a post last week, I was critical of the Connecticut Stem Cell Initiative, a 4-year-old program that was cut out of [...] [...] a post last week, I was critical of the Connecticut Stem Cell Initiative, a 4-year-old program that was cut out of [...]

]]> By: Joseph B. Franklin http://yalepatents.org/2009/12/30/stem-cell-program-policy-diversion-for-a-lagging-connecticut/comment-page-1/#comment-115 Joseph B. Franklin Thu, 31 Dec 2009 02:55:41 +0000 http://yalepatents.org/?p=617#comment-115 I don't claim that the Connecticut stem-cell funding is "wasted"; at least from one perspective, it's extremely generous of CT residents to be funding progressive science, particularly when the economic situation is so dire. However, simply because something, arguably, isn't wasteful doesn't make it good policy. As for professors lobbying for more funds (and the list you cite includes some very good researchers), I would expect the same out of anyone with a research or business plan to support. However, there is a deceptively weak link between such scientific enthusiasm and a revitalized state economy. I don’t claim that the Connecticut stem-cell funding is “wasted”; at least from one perspective, it’s extremely generous of CT residents to be funding progressive science, particularly when the economic situation is so dire. However, simply because something, arguably, isn’t wasteful doesn’t make it good policy. As for professors lobbying for more funds (and the list you cite includes some very good researchers), I would expect the same out of anyone with a research or business plan to support. However, there is a deceptively weak link between such scientific enthusiasm and a revitalized state economy.

]]> By: Pete http://yalepatents.org/2009/12/30/stem-cell-program-policy-diversion-for-a-lagging-connecticut/comment-page-1/#comment-114 Pete Thu, 31 Dec 2009 01:58:50 +0000 http://yalepatents.org/?p=617#comment-114 This is an interesting opinion but I am a bit confused. At a hearing in Hartford on the Governor's proposed cut of the $10million funding for the state's Stem Cell program professors from Yale and Uconn testified how important the funding was for future research and leveraging Federal dollars. Were they wrong? Here is a partial list of the $9.8million the state released in April of this year. If it is just wasted money thank you for telling everyone. That is to much money to waste. Thanks Continuing and Enhancing the UCONN-Wesleyan Stem Cell Core, University of Connecticut Stem Cell Center, Farmington, Ren-He Xu, MD, PhD, Principal Investigator, $1,900,000.00. Williams Syndrome Associated TFII-I Factor and Epigenetic Marking-Out in hES and Induced Pluripotent Stem Cells, University of Connecticut Health Center, Farmington, Dashzeveg Bayarsaihan, PhD., Principal Investigator, $500,000.00. Cellular transplantation of neural progenitors derived from human embryonic stem cells to remyelinate the nonhuman primate spinal cord, Yale University, New Haven, Jeffrey Kocsis, PhD., Principal Investigator, $500,000.00. Mechanisms of Stem Cell Homing to the Injured Heart, University of Connecticut HealthCenter, Linda Shapiro, PhD., Principal Investigator, $500,000.00. Genome-wide screen to identify hESC-specific DNA transcription elements, Yale University, New Haven, Richard Sutton, MD, PhD., Principal Investigator, $500,000.00. Molecular function of Lin28 in human embryonic stem cells, Yale University, New Haven, Yingqun Huang, MD, PhD., Principal Investigator, $500,000.00. Therapeutic differentiation of regulatory T cells from iPS and hES for immune tolerance, University of Connecticut Health Center, Zihai Li, MD, PhD., Principal Investigator, $500,000.00. Prevention of Spontaneous Differentiation and Epigenetic Compromise of Human ES and iPS Cells, University of Connecticut, Storrs, Theodore Rasmussen, PhD., PrincipalInvestigator, $499,956.00. Development of iPS cells to study craniometaphyseal dysplasia in humans, University of Connecticut Health Center, Farmington, Alex Lichtler, PhD., Principal Investigator, $500,000.00 piggyBac Transposon for Genetic Manipulation and Insertional Mutagenesis in Human Embryonic Stem Cells, Yale University, New Haven, Tian Xu, PhD., Principal Investigator, $500,000.00. Brain Grafts of GABAergic Neuron Precursors Derived from Human and Mouse ES Cells for Treating Temporal Lobe Epilepsy, Wesleyan University, Middletown, JaniceNaegele, PhD., Principal Investigator, $499,988.00. MicroRNA regulation of hESC fates, Yale University, New Haven, Jun Lu, PhD., Principal Investigator, $500,000.00. This is an interesting opinion but I am a bit confused. At a hearing in Hartford on the Governor’s proposed cut of the $10million funding for the state’s Stem Cell program professors from Yale and Uconn testified how important the funding was for future research and leveraging Federal dollars. Were they wrong? Here is a partial list of the $9.8million the state released in April of this year. If it is just wasted money thank you for telling everyone. That is to much money to waste.

Thanks

Continuing and Enhancing the UCONN-Wesleyan Stem Cell Core, University of
Connecticut Stem Cell Center, Farmington, Ren-He Xu, MD, PhD, Principal Investigator,
$1,900,000.00.

Williams Syndrome Associated TFII-I Factor and Epigenetic Marking-Out in hES and Induced Pluripotent Stem Cells, University of Connecticut Health Center, Farmington, Dashzeveg Bayarsaihan, PhD., Principal Investigator, $500,000.00.

Cellular transplantation of neural progenitors derived from human embryonic stem cells to remyelinate the nonhuman primate spinal cord, Yale University, New Haven, Jeffrey Kocsis, PhD., Principal Investigator, $500,000.00.

Mechanisms of Stem Cell Homing to the Injured Heart, University of Connecticut HealthCenter, Linda Shapiro, PhD., Principal Investigator, $500,000.00.

Genome-wide screen to identify hESC-specific DNA transcription elements, Yale
University, New Haven, Richard Sutton, MD, PhD., Principal Investigator, $500,000.00.

Molecular function of Lin28 in human embryonic stem cells, Yale University, New Haven, Yingqun Huang, MD, PhD., Principal Investigator, $500,000.00.

Therapeutic differentiation of regulatory T cells from iPS and hES for immune tolerance, University of Connecticut Health Center, Zihai Li, MD, PhD., Principal Investigator, $500,000.00.

Prevention of Spontaneous Differentiation and Epigenetic Compromise of Human ES and iPS Cells, University of Connecticut, Storrs, Theodore Rasmussen, PhD., PrincipalInvestigator, $499,956.00.

Development of iPS cells to study craniometaphyseal dysplasia in humans, University of
Connecticut Health Center, Farmington, Alex Lichtler, PhD., Principal Investigator,
$500,000.00

piggyBac Transposon for Genetic Manipulation and Insertional Mutagenesis in Human
Embryonic Stem Cells, Yale University, New Haven, Tian Xu, PhD., Principal
Investigator, $500,000.00.

Brain Grafts of GABAergic Neuron Precursors Derived from Human and Mouse ES Cells for Treating Temporal Lobe Epilepsy, Wesleyan University, Middletown, JaniceNaegele, PhD., Principal Investigator, $499,988.00.

MicroRNA regulation of hESC fates, Yale University, New Haven, Jun Lu, PhD.,
Principal Investigator, $500,000.00.

]]>